Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome

Related Experiment Video

Updated: Aug 16, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Shu Ye1

  • 1Human Genetics Division, School of Medicine, University of Southampton, UK. Shu.Ye@soton.ac.uk

Cardiovascular Research
|August 27, 2005
PubMed

Insights

Matrix metalloproteinase (MMP) gene variations influence cardiovascular disease risk and outcomes. MMP gene polymorphisms, particularly in MMP3, are linked to various cardiovascular conditions, highlighting their role in disease development.

Area of Science:

  • Genetics
  • Cardiovascular Medicine
  • Molecular Biology

Background:

  • Matrix metalloproteinases (MMPs) are enzymes involved in extracellular matrix remodeling.
  • Accumulating evidence suggests MMP gene polymorphisms contribute to cardiovascular disease (CVD) susceptibility and outcomes.
  • Inter-individual variability in CVD may be partly explained by genetic factors affecting MMP function.

Purpose of the Study:

  • To review the role of matrix metalloproteinase (MMP) gene polymorphisms in cardiovascular disease.
  • To highlight the association of specific MMP polymorphisms with various cardiovascular conditions.
  • To explore the potential clinical utility of MMP genotyping in patient management.

Main Methods:

  • Literature review of studies investigating MMP gene polymorphisms and cardiovascular disease.
  • Analysis of associations between specific MMP polymorphisms (e.g., MMP3 5A/6A) and clinical outcomes.
  • Examination of functional evidence linking MMPs to cardiovascular pathogenesis.

Main Results:

  • The MMP3 gene 5A/6A polymorphism significantly impacts MMP3 expression and is associated with coronary stenosis, myocardial infarction, and atherosclerosis.
  • Polymorphisms in MMP1, MMP2, MMP7, MMP9, MMP12, and MMP13 genes are linked to coronary artery disease, arterial stiffness, and abdominal aortic aneurysm.
  • These genetic associations support the critical role of MMPs in the development of cardiovascular diseases.

Conclusions:

  • MMP gene polymorphisms are significant contributors to cardiovascular disease risk and progression.
  • MMP genotyping may assist in identifying patients with poor prognosis or adverse treatment responses.
  • Targeting MMP pathways could represent a future therapeutic strategy for cardiovascular conditions.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...